查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
亚太地区基因测序市场（按产品、最终用户和国家划分）分析与预测（2024-2033 年）
市场调查报告书
商品编码
1643948

亚太地区基因测序市场（按产品、最终用户和国家划分）分析与预测（2024-2033 年）

Asia-Pacific Genome Sequencing Market: Focus on Product, End User, and Country - Analysis and Forecast, 2024-2033
出版日期: | 出版商: BIS Research | 英文 72 Pages | 商品交期: 1-5个工作天内

价格

预计2024年亚太地区基因测序市场规模将达13亿美元。

预计 2024 年至 2033 年期间市场复合年增长率为 18.44%，2033 年达到 59.6 亿美元。科学家可以透过确定生物体的整个 DNA 序列来破解生物体的整个基因组成，这个过程称为基因序列测定。此步骤对于发现基因变异并了解其对健康和疾病的可能影响是必要的。由于使用次世代定序(NGS) 技术的产前和新生儿筛检计画的需求不断增加、基因检测的采用率不断提高以及定序成本下降，亚太地区的基因测序市场正在快速成长。

不断扩大的市场是长读定序应用日益广泛的结果，它能够为复杂的遗传资料提供更准确、更详细的洞察。此外，亚太地区各地的政府计画和投资正在加速基因测序技术的采用，改善医疗和科学应用的可近性。

主要市场统计数据
预测期 2024-2033
2024 年评估 13亿美元
2033 年预测 59.6亿美元
复合年增长率 18.44％

随着该地区继续优先考虑医疗保健进步和精准医疗，基因测序正在成为增强诊断、个人化治疗和疾病预防的重要工具。这些因素预计将推动创新、增加消费者的获取途径并塑造亚太地区基因测序市场的未来。

由于测序技术的进步、价格的下降以及研究和医疗保健行业对基因检测的需求不断增加，亚太地区基因测序市场正在迅速扩张。基因定序是精准医疗的关键组成部分，它可以揭示生物体的整个 DNA 序列，有助于更好地预防疾病、制定个人化治疗方案和增强诊断。

市场扩张的主要驱动力之一是次世代定序（NGS）在癌症诊断、罕见疾病识别以及产前和新生儿筛检的应用日益广泛。长读定序技术可以让人们详细了解复杂的遗传资料，该技术在该领域也变得越来越普遍。

为了加速定序技术的推广，亚太地区各国政府正大力投资基因组研究和医疗保健基础设施。这些项目以及教育机构和私人公司之间的合作提高了可近性和创新性。

本报告研究了亚太地区的基因测序市场，并提供了市场概况、产品、最终用户和国家趋势以及参与市场的公司概况。

目录

执行摘要

第一章基因测序市场：产业分析

  • 主要趋势：当前和未来的影响评估
  • 监管分析
  • 价值和供应链分析

第二章基因测序市场：市场动态

  • 影响分析
  • 市场驱动因素
  • 市场限制
  • 市场机会

第三章基因测序市场：未来展望

  • 专利分析
  • 竞争性基准化分析
  • 临床实施顺序
  • 未来展望

第四章基因测序市场（按地区）

  • 区域概况
  • 驱动因素与限制因素
  • 亚太地区
    • 区域概况
    • 市场驱动因素
    • 市场限制
    • 按产品
    • 按最终用户
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 其他的

基准化分析5基因测序。

  • 关键策略和发展
    • 伙伴关係、合作和业务扩展
    • 监管和法律活动
    • 新服务
    • 合併和收购
    • 资金筹措活动
  • 公司简介
    • MGI Tech Co., Ltd.

第六章调查方法

Product Code: BHP2488SS

Introduction to Asia-Pacific Genome Sequencing Market

The Asia-Pacific genome sequencing market was valued at $1.30 billion in 2024 and is expected to reach $5.96 billion by 2033, growing at a CAGR of 18.44% between 2024 and 2033. Scientists can decipher an organism's entire genetic composition by determining its entire DNA sequence, a process known as genome sequencing. Finding genetic variations and comprehending their possible effects on health and illness require this procedure. Due to rising demand for prenatal and neonatal screening programs using next-generation sequencing (NGS) technologies, growing adoption of genetic testing, and falling sequencing costs, the genome sequencing market in Asia-Pacific is growing quickly.

The market is growing as a result of long-read sequencing's growing applications, which offer more precise and in-depth insights into complicated genetic data. Furthermore, government programs and investments throughout Asia-Pacific are speeding up the adoption of genome sequencing technologies and improving accessibility for medical and scientific applications.

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$1.30 Billion
2033 Forecast$5.96 Billion
CAGR18.44%

As the area continues to prioritize healthcare advancements, and precision medicine, genome sequencing is emerging as a vital tool for enhancing diagnostics, personalized treatments, and disease prevention. These factors are expected to drive innovation and expand consumer access, shaping the future of the genome sequencing market in APAC.

Market Introduction

The market for APAC genome sequencing is expanding quickly due to improvements in sequencing technology, falling prices, and an increase in the need for genetic testing in the research and healthcare industries. A key component of precision medicine, genome sequencing reveals an organism's entire DNA sequence, facilitating better disease prevention, individualized treatment plans, and enhanced diagnostics.

One of the main factors propelling market expansion is the growing use of next-generation sequencing (NGS) in cancer diagnostics, rare disease identification, and prenatal and neonatal screening. Technologies for long-read sequencing, which offer in-depth understanding of intricate genetic data, are also becoming more popular in the area.

To hasten the adoption of sequencing technologies, governments throughout Asia-Pacific are making significant investments in genomic research and healthcare infrastructure. These programs, along with partnerships among educational institutions and private companies, are enhancing accessibility and innovation.

As the region prioritizes advancements in healthcare and precision medicine, the APAC genome sequencing market is poised for sustained growth, transforming medical research and improving patient outcomes.

Market Segmentation

Segmentation 1: by Product

  • Kits
  • Instruments
  • Software

Segmentation 2: by End User

  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Diagnostic Laboratories
  • Population Sequencing Organizations
  • Research and Academic Institutes
  • Others

Segmentation 3: by Region

  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific genome sequencing market has been segmented based on various categories, such as by product, end user, and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: Partnerships, alliances, funding, new offerings, and business expansions together accounted for the maximum number of key developments of the total developments in the Asia-Pacific genome sequencing market.

Competitive Strategy: The Asia-Pacific genome sequencing market is a highly fragmented market, with many public and few private companies. Key players in the Asia-Pacific genome sequencing market analyzed and profiled in the study involve established players that offer various kinds of products.

Table of Contents

Executive Summary

Scope and Definition

1 Genome Sequencing Market: Industry Analysis

  • 1.1 Key Trends: Current and Future Impact Assessment
    • 1.1.1 Integration of Artificial Intelligence and Machine Learning in Genome Sequencing
    • 1.1.2 Increasing Partnerships, Alliances, and Business Expansions among Key Players
  • 1.2 Regulatory Analysis
  • 1.3 Value and Supply Chain Analysis

2 Genome Sequencing Market: Market Dynamics

  • 2.1 Impact Analysis
  • 2.2 Market Drivers
    • 2.2.1 Decreasing Cost of Genome Sequencing Enabling High Usage of Genome Sequencing/Testing
    • 2.2.2 Rising Prenatal and New-Born Screening Programs Facilitating the Demand for Next-Generation Sequencing
    • 2.2.3 Expanding Applications of Long-Read Sequencing
    • 2.2.4 Government Investments and Initiatives in Genome Sequencing Projects
  • 2.3 Market Restraints
    • 2.3.1 Data Management Challenges in Genome Sequencing
    • 2.3.2 Genomic Data Disparity in Developing Countries
  • 2.4 Market Opportunities
    • 2.4.1 Emergence of Portable Genome Sequencing Enabling Bedside Testing
    • 2.4.2 Multiomics Shaping the Global Genome Sequencing Landscape

3 Genome Sequencing Market: Future Outlook

  • 3.1 Patent Analysis
    • 3.1.1 Patent Analysis (by Year)
    • 3.1.2 Patent Analysis (by Country)
  • 3.2 Competitive Benchmarking
    • 3.2.1 Market Share
    • 3.2.2 Brand Recognition
  • 3.3 Sequencing Clinical Adoption
  • 3.4 Future Outlook

4 Genome sequencing market (By Region)

  • 4.1 Regional Summary
  • 4.2 Drivers and Restraints
  • 4.3 Asia-Pacific
    • 4.3.1 Regional Overview
    • 4.3.2 Driving Factors for Market Growth
    • 4.3.3 Factors Challenging the Market
    • 4.3.4 By Product
    • 4.3.5 By End User
    • 4.3.6 China
      • 4.3.6.1 By Product
    • 4.3.7 Japan
      • 4.3.7.1 By Product
    • 4.3.8 India
      • 4.3.8.1 By Product
    • 4.3.9 Australia
      • 4.3.9.1 By Product
    • 4.3.10 South Korea
      • 4.3.10.1 By Product
    • 4.3.11 Rest-of-Asia-Pacific
      • 4.3.11.1 By Product

5 Genome sequencing market - Competitive Benchmarking and Company Profiles

  • 5.1 Key Strategies and Development
    • 5.1.1 Partnerships, Alliances, and Business Expansions
    • 5.1.2 Regulatory and Legal Activities
    • 5.1.3 New Offerings
    • 5.1.4 Mergers and Acquisitions
    • 5.1.5 Funding Activities
  • 5.2 Company Profiles
    • 5.2.1 MGI Tech Co., Ltd.
      • 5.2.1.1 Overview
      • 5.2.1.2 Top Products and Services
      • 5.2.1.3 Top Competitors
      • 5.2.1.4 Key Personnel
      • 5.2.1.5 Analyst View

6 Research Methodology

  • 6.1 Data Sources
    • 6.1.1 Primary Data Sources
    • 6.1.2 Secondary Data Sources
    • 6.1.3 Data Triangulation

List of Figures

  • Figure 1: Asia-Pacific Genome Sequencing Market, $Billion, 2024, 2028, and 2033
  • Figure 2: Genome Sequencing Market (by Region), $Billion, 2023, 2027, and 2033
  • Figure 3: Asia-Pacific Genome Sequencing Market (by End User), $Billion, 2023, 2027, and 2033
  • Figure 4: Asia-Pacific Genome Sequencing Market (by Product), $Billion, 2023, 2027, and 2033
  • Figure 5: Key Players' Strategic Priorities
  • Figure 6: Potential Future Directions
  • Figure 7: Companies Utilizing Artificial Intelligence in Genomics
  • Figure 8: Share of Partnerships, Alliances, and Business Expansions vs Other Strategies
  • Figure 9: Some of the Key Partnerships, Alliances, and Business Expansions and their Impact on the Sequencing Market
  • Figure 10: Value and Supply Chain Analysis, Genome Sequencing Market
  • Figure 11: Impact Analysis of Market Dynamics, 2022-2033
  • Figure 12: Genome Sequencing Cost Over Time, 2007-2024
  • Figure 13: Newborn Screening Program of Some of the Countries
  • Figure 14: Some Aspects of Long-Read Sequencing
  • Figure 15: Some of the Genome Sequencing Initiatives
  • Figure 16: Volume of Different Genetic Tests, Size in Base Pairs (bp)
  • Figure 17: Genome Sequencing Market, Patent Analysis (by Year), January 2021-December 2023
  • Figure 18: Genome Sequencing Market, Patent Analysis (by Country), January 2021-December 2023
  • Figure 19: Genome Sequencing Market, Market Share, 2023
  • Figure 20: Clinical Utility of Genome Sequencing
  • Figure 21: Future Outlook for Genome Sequencing
  • Figure 22: China Genome Sequencing Market, $Billion, 2023-2033
  • Figure 23: Japan Genome Sequencing Market, $Billion, 2023-2033
  • Figure 24: Australia Genome Sequencing Market, 2022-2033
  • Figure 25: South Korea Genome Sequencing Market, $Billion, 2023-2033
  • Figure 26: Rest-of-Asia-Pacific Genome Sequencing Market, $Billion, 2023-2033
  • Figure 27: Partnerships, Alliances, and Business Expansions Activities, January 2020-April 2024
  • Figure 28: Regulatory and Legal Activities, January 2020-April 2024
  • Figure 29: New Offerings, January 2020-April 2024
  • Figure 30: Mergers and Acquisitions, January 2020-April 2024
  • Figure 31: Funding Activities, January 2020-April 2024
  • Figure 32: Data Triangulation
  • Figure 33: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Genome Sequencing Market, Market Opportunities
  • Table 3: Current and Future Impact of Trends
  • Table 4: Regulatory Landscape (by Country)
  • Table 5: Output and Approximate Required Disk Space to Store an Instrument Run
  • Table 6: Comparison of Some of the Key Sequencers
  • Table 7: Genome sequencing market (by Region), $Billion, 2023-2033
  • Table 8: Asia-Pacific Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 9: Asia-Pacific Genome Sequencing Market (by End User), $Billion, 2023-2033
  • Table 10: China Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 11: Japan Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 12: India Genome Sequencing Market, $Billion, 2023-2033
  • Table 13: India Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 14: Australia Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 15: South Korea Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 16: Rest-of-Asia-Pacific Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 17: Genome Sequencing Market, Key Development Analysis, January 2020-April 2024